Roles of PPARγ/NF-κB signaling pathway in the pathogenesis of intrahepatic cholestasis of pregnancy

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Zhang, Yan ^a,b   Hu, Lingqing ^a   Cui, Yan ^b   Qi, Zhigang ^c   Huang, Xiaoping ^a   Cai, Liyi ^a   Zhang, Ting ^a   Yin, Yongxiang ^a   Lu, Zhiyi ^d   Xiang, Jingying ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

^d Wuxi Hospital of Traditional Chinese Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILE ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL DIFFERENTIATION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INTRAHEPATIC CHOLESTASIS; LIPID BLOOD LEVEL; LIPID TRANSPORT; LIVER FUNCTION; PATHOGENESIS; PREGNANCY; PROTEIN BLOOD LEVEL; PROTEIN DENATURATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; TROPHOBLAST;

ADULT; CASE-CONTROL STUDIES; CELL LINE; CHOLESTASIS, INTRAHEPATIC; FEMALE; GENE EXPRESSION; HUMANS; NF-KAPPA B; PLACENTA; PPAR GAMMA; PREGNANCY; PREGNANCY COMPLICATIONS; SIGNAL TRANSDUCTION; TROPHOBLASTS; YOUNG ADULT;

EID: 84900465324     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087343     Document Type: Article

References (77)

1. Joshi D, James A, Quaglia A, Westbrook RH, Heneghan MA (2010) Liver disease in pregnancy. Lancet 375: 594-605.
2. Kenyon AP, Girling JC (2011) Obstetricscholestasis. RCOG green-top guidelines No 43. London: RCOG.
3. Geenes V, Williamson C (2009) Intrahepatic cholestasis of pregnancy. World J Gastroenterol15: 2049-2066.
4. Rook M, Vargas J, Caughey A, Bacchetti P, Rosenthal P, et al. (2012) Fetal outcomes in pregnancies complicated by intrahepatic cholestasis of pregnancy in a Northern California cohort. PLoS One 7: e28343.
5. Chen J, Deng W, Wang J, Shao Y, Ou M, et al.(2013) Primary bile acids as potential biomarkers for the clinical grading of intrahepatic cholestasis of pregnancy. Int J Gynaecol Obstet 122:5-8.
6. Savander M, Ropponen A, Avela K, Weerasekera N, Cormand B, et al. (2003) Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy. Gut52: 1025-1029. (Pubitemid 36765296)
7. Liu XH, He J (2011) Pay more attention to standardizing the diagnosis and treatment of intrahepatic cholestasis of pregnancy. Zhonghua Fu Chan Ke Za Zhi 46: 321-323.
8. Painter JN, Savander M, Ropponen A, Nupponen N, Riikonen S, et al. (2005) Sequence variation in the ATP8B1 gene and intrahepatic cholestasis of pregnancy. Eur J Hum Genet 13: 435-439. (Pubitemid 40520934)
9. Reyes H (2008) Sex hormones and bile acids in intrahepatic cholestasis of pregnancy. Hepatology47: 376-379.
10. Diken Z, Usta IM, Nassar AH (2013) A Clinical Approach to Intrahepatic Cholestasis of Pregnancy. Am J Perinatol.
11. Yayi H, Danqing W, Shuyun L, Jicheng L (2010) Immunologic abnormality of intrahepatic cholestasis of pregnancy. Am J Reprod Immunol 63: 267-273.
12. Zhou F, He MM, Liu ZF, Zhang L, Gao BX, et al. (2013) Expression of corticotrophin-releasing hormone and its receptor in patients with intrahepatic cholestasis of pregnancy. Placenta 34: 401-406.
13. Wei J, Wang H, Yang X, Dong M, Wang Z (2010) Altered gene profile of placenta from women with intrahepatic cholestasis of pregnancy. Arch Gynecol Obstet 281: 801-810.
14. Ling B, Yao F, Zhou Y, Chen Z, Shen G, et al. (2007) Cell-mediated immunity imbalance in patients with intrahepatic cholestasis of pregnancy. Cell Mol Immunol 4: 71-75.
15. Denney JM, Nelson EL, Wadhwa PD, Waters TP, Mathew L, et al. (2011) Longitudinal modulation of immune system cytokine profile during pregnancy. Cytokine 53: 170-177.
16. Rieger L, Hofmeister V, Probe C, Dietl J, Weiss EH, et al. (2002) Th1- and Th2- like cytokine production by first trimester decidual large granular lymphocytes is influenced by HLA-G and HLA-E. Mol Hum Reprod 8: 255-261. (Pubitemid 34196352)
17. Wegmann TG, Lin H, Guilbert L, Mosmann TR (1993) Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 14: 353-356. (Pubitemid 23198169)
18. Shi Q, Liu S, Xiong Q (1998) The changes of serum estrogen, progesterone and the function of immune system in intrahepatic cholestasis of pregnancy. Zhonghua Fu Chan Ke Za Zhi 33: 292-294.
19. McCracken SA, Gallery E, Morris JM (2004) Pregnancy-specific down-regulation of NF-kappa B expression in T cells in humans is essential for the maintenance of the cytokine profile required for pregnancy success. J Immunol 172: 4583-4591. (Pubitemid 38375276)
20. Hadfield KA, McCracken SA, Ashton AW, Nguyen TG, Morris JM (2011) Regulated suppression of NF-κB throughout pregnancy maintains a favourable cytokine environment necessary for pregnancy success. J Reprod Immunol 89: 1-9.
21. Schaiff WT, Barak Y, Sadovsky Y (2001) The pleiotropic function of PPAR gamma in the placenta. Mol Cell Endocrinol 249: 10-15.
22. Fournier T, Tsatsaris V, Handschuh K, Evain-Brion D (2007) PPARs and the placenta. Placenta 28: 65-76. (Pubitemid 44929358)
23. Hutter S, Knabl J, Andergassen U, Jeschke U (2013) The Role of PPARs in Placental Immunology: A Systematic Review of the Literature. PPAR Res 2013: 970276.
24. Belfort R, Berria R, Cornell J, Cusi K (2010) Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome. J Clin Endocrinol Metab 95: 829-836.
25. Lefebvre P, Chinetti G, Fruchart JC, Staels B (2006) Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest 116: 571-580. (Pubitemid 43326861)
26. Martínez N, Capobianco E, White V, Pustovrh MC, Higa R, et al. (2008) Peroxisome proliferator-activated receptor alpha activation regulates lipid metabolism in the feto-placental unit from diabetic rats. Reproduction 136: 95-103. (Pubitemid 351984723)
27. Vanden Berghe W, Vermeulen L, Delerive P, De Bosscher K, Staels B, et al. (2003) A paradigm for gene regulation: inflammation, NF-kappaB and PPAR. Adv Exp Med Biol 544: 181-196. (Pubitemid 38326569)
28. Poynter ME, Daynes RA (1998) Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. J Biol Chem 273: 32833-32841. (Pubitemid 28557672)
29. Beaven SW, Tontonoz P (2006) Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia. Annu Rev Med 57: 313-329. (Pubitemid 43261994)
30. Youssef J, Badr M (2004) Role of Peroxisome Proliferator-Activated Receptors in Inflammation Control. J Biomed Biotechnol 2004: 156-166. (Pubitemid 39287736)
31. Mandard S, Patsouris D (2013) Nuclear control of the inflammatory response in mammals by peroxisome proliferator-activated receptors. PPAR Res 2013: 613864.
32. Lappas M, Permezel M, Georgiou HM, Rice GE (2002) Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-gamma: effect of 15-deoxy-Delta(12,14)-PGJ(2) and troglitazone. J Clin Endocrinol Metab 87: 4667-4672. (Pubitemid 35247059)
33. Genolet R, Wahli W, Michalik L (2004) PPARs as drug targets to modulate inflammatory responses? Curr Drug Targets Inflamm Allergy 3: 361-375. (Pubitemid 39534773)
34. Kelly D, Campbell JI, King TP, Grant G, Jansson EA, et al.(2004) Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 5: 104-112. (Pubitemid 38081475)
35. Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, et al. (1999) A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Invest 104: 383-389. (Pubitemid 29534322)
36. Wang LH, Yang XY, Zhang X, Farrar WL (2007) Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBP. Blood 110: 4373-4384. (Pubitemid 351377804)
37. Prins JR, Gomez-Lopez N, Robertson SA (2012) Interleukin-6 in pregnancy and gestational disorders. J Reprod Immunol 95: 1-14.
38. Fitzgerald K (2001) The cytokine factsbook, 2nd ed. The factsbook series. San Diego, CA: Academic Pressp: 515.
39. Hauguel-de Mouzon S, Guerre-Millo M (2006) The placenta cytokine network and inflammatory signals. Placenta 27: 794-798. (Pubitemid 43947814)
40. Ai Y, Liu SY (2004) Influence of transforming growth factor-beta2 on production of tumor necrosis factor-alpha and interferon-gamma from placenta of intrahepatic cholestasis of pregnancy. Zhonghua Fu Chan Ke Za Zhi 39: 322-325.
41. Desoye G, Hauguel-de Mouzon S (2011) The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care 30: S120- S126.
42. Denison FC, Roberts KA, Barr SM, Norman JE (2010) Obesity, pregnancy, inflammation, and vascular function. Reproduction 140: 373-385.
43. Aye IL, Waddell BJ, Mark PJ, Keelan JA (2012) Oxysterols exert proinflammatory effects in placental trophoblasts via TLR4-dependent, cholesterolsensitive activation of NF-κB. Mol Hum Reprod 8: 341-353.
44. Graham CH, Hawley TS, Hawley RG, MacDougall JR, Kerbel RS, et al. (1993) Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res 206: 204-211. (Pubitemid 23212937)
45. Glantz A, Marschall HU, Mattsson LA (2004) Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology 40: 467-474. (Pubitemid 39062865)
46. Geenes VL, Lim YH, Bowman N, Tailor H, Dixon PH, et al. (2011) A placental phenotype for intrahepatic cholestasis of pregnancy. Placenta 32: 1026-1032.
47. Calleja-Agius J, Jauniaux E, Pizzey AR, Muttukrishna S (2012) Investigation of systemic inflammatory response in first trimester pregnancy failure. Hum Reprod 27: 349-357.
48. Wegmann TG, Guilbert LJ (1992) Immune signalling at the maternal-fetal interface and trophoblast differentiation. Dev Comp Immunol 16: 425-430.
49. Sykes L, MacIntyre DA, Yap XJ, Ponnampalam S, Teoh TG, et al. (2012) Changes in the Th1:Th2 cytokine bias in pregnancy and the effects of the anti-inflammatory cyclopentenone prostaglandin 15-deoxy-D(12,14)-prostaglandin J2. Mediators Inflamm 2012: 416739.
50. Marie C, Pitton C, Fitting C, Cavaillon JM (1996) Regulation by anti-inflammatory cytokines (IL-4, IL-10, IL-13, TGFbeta) of interleukin-8 production by LPS- and/or TNFalpha-activated human polymorphonuclear cells. Mediators Inflamm 5: 334-340. (Pubitemid 26395399)
51. O'Garra A, Arai N (2000) The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol 10: 542-550.
52. Greig PC, Murtha AP, Jimmerson CJ, Herbert WN, Roitman-Johnson B, et al. (1997) Maternal serum interleukin-6 during pregnancy and during term and preterm labor. Obstet Gynecol 90: 465-469. (Pubitemid 27357943)
53. Zeng C, Xiao JH, Chang MJ, Wang JL (2011) Beneficial effects of THSG on acetic acid-induced experimental colitis: involvement of upregulation of PPAR-c and inhibition of the Nf-Kb inflammatory pathway. Molecules 16: 8552-8568.
54. Carpentier PA, Dingman AL, Palmer TD (2011) Placental TNF-a signaling in illness-induced complications of pregnancy. Am J Pathol 178: 2802-2810.
55. Du Q, Zhang Y, Pan Y, Duan T (2013) Lithocholic acid-induced placental tumor necrosis factor-α upregulation and syncytiotrophoblast cell apoptosis in intrahepatic cholestasis of pregnancy. Hepatol Res.
56. Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF 3rd, et al. (2009) Inflammation and pregnancy. Reprod Sci 16: 206-215.
57. Murthi P, Kalionis B, Cocquebert M, Rajaraman G, Chui A, et al. (2013) Homeobox genes and down-stream transcription factor PPARγ in normal and pathological human placental development. Placenta 34: 299-309.
58. Rusterholz C, Hahn S, Holzgreve W (2007) Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia. Semin Immunopathol 29: 151-162. (Pubitemid 47596394)
59. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, et al. (1999) PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4: 585-595. (Pubitemid 29531138)
60. Barak Y, Sadovsky Y, Shalom-Barak T (2008) PPAR Signaling in Placental Development and Function. PPAR Res 2008: 142082.
61. Borel V, Gallot D, Marceau G, Sapin V, Blanchon L (2008) Placental implications of peroxisome proliferator-activated receptors in gestation and parturition. PPAR Res 2008: 1-9.
62. Fournier T, Guibourdenche J, Handschuh K, Tsatsaris V, Rauwel B, et al. (2011) PPARγ and human trophoblast differentiation. J Reprod Immunol 90: 41-49.
63. Shalom-Barak T, Zhang X, Chu T, Timothy Schaiff W, Reddy JK, et al. (2012) Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. Dev Biol 372: 143-155.
64. Luconi M, Cantini G, Serio M (2010) Peroxisome proliferator-activated receptor gamma (PPARgamma): is the genomic activity the only answer? Steroids 75: 585-594.
65. Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W (2012) From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog Lipid Res 45: 120-159.
66. Waite LL, Person EC, Zhou Y, Lim KH, Scanlan TS, et al. (2000) Placental peroxisome proliferator-activated receptor-gamma is up-regulated by pregnancy serum. J Clin Endocrinol Metab 85: 3808-3814.
67. Ben-Neriah Y (2002) Regulatory functions of ubiquitination in the immune system. Nat Immunol 3: 20-26.
68. Ghosh S, Karin M (2002) Missing pieces in the NF-kappaB puzzle. Cell 109: S81-S96.
69. Liu ZJ, Yao Q, Liu SY (2008) Expression of NF-kappaB and COX-2 in placenta tissues of patients with intrahepatic cholestasis of pregnancy and its significance. Zhonghua Fu Chan Ke Za Zhi 43: 292-294.
70. Lappas M, Permezel M, Georgiou HM, Rice GE (2002) Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol Reprod 67: 668-673. (Pubitemid 34803959)
71. Lappas M, Permezel M, Rice GE (2003) N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-kappaB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J Clin Endocrinol Metab 88: 1723-1729. (Pubitemid 36623395)
72. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK (1998) The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79-82. (Pubitemid 28079218)
73. Moraes LA, Piqueras L, Bishop-Bailey D (2006) Peroxisome proliferatoractivated receptors and inflammation. Pharmacol Ther 110: 371-85.
74. Chaouat G, Ledee-Bataille N, Dubanchet S, Zourbas S, Sandra O, et al. (2012) Reproductive immunology 2003: reassessing the Th1/Th2 paradigm? Immunol Lett 92: 207-14.
75. Dann AT, Kenyon AP, Wierzbicki AS, Seed PT, Shennan AH, et al. (2006) Plasma lipid profiles of women with intrahepatic cholestasis of pregnancy. Obstet Gynecol 107: 106-114.
76. Abu-Hayyeh S, Papacleovoulou G, Lövgren-Sandblom A, Tahir M, Oduwole O, et al. (2013) Intrahepatic cholestasis of pregnancy levels of sulfated progesterone metabolites inhibit farnesoid X receptor resulting in a cholestatic phenotype. Hepatology 57: 716-726.
77. Wikström Shemer E, Thorsell M, Östlund E, Blomgren B, Marschall HU (2012) Stereological assessment of placental morphology in intrahepatic cholestasis of pregnancy. Placenta 33: 914-918.